Matthew Bott, MD

About Me

I am a surgeon who specializes in treating cancers of the chest. These types of cancers include lung cancer, esophageal cancer, thymic tumors, neuroendocrine tumors, and mesothelioma. I have experience in using the latest technology to diagnose and treat a wide variety of diseases of the lung, esophagus, and chest wall. I perform these operations through small incisions with the goal of minimizing discomfort and accelerating recovery. I also focus on techniques and procedures to improve symptoms and quality of life in people with advanced cancer. Working with my colleagues in medical and radiation oncology, we emphasize treatment plans that are unique and are tailored to each patient’s needs.

I also have an interest in benign conditions such as anti-reflux procedures, hiatal hernia repair, and surgery for achalasia. Once again, I believe in using a minimally invasive approach in order to help people heal quickly and return to their daily activities.

A significant portion of my time is also spent performing scientific research to better understand how tumors form and investigate new ways to treat them. Using a patient-centered approach, I am working to design new models to study cancer and then use these experimental models to develop better treatments. It is my hope that discoveries made in the laboratory will result in more effective therapies and will ultimately help to cure people afflicted by these diseases.

  • Clinical Expertise: Lung and Esophageal Cancers; Thymic Malignancies; Pulmonary Metastases; Mesothelioma; Minimally Invasive Surgery; Video-Assisted Thoracic Surgery (VATS); EBUS; Rigid Bronchoscopy; Tracheobronchial and Esophageal Stents
  • Languages Spoken: English
  • Education: MD, University of Virginia
  • Residencies: General Surgery - New York Presbyterian/Weill Cornell Medical Center
  • Fellowships: Surgery - Washington University at St. Louis
  • Board Certifications: General Surgery; Cardiothoracic Surgery

See My Colleagues


Visit PubMed for a full listing of Matthew Bott’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.